HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Li Jia Selected Research

Prostatic Neoplasms (Prostate Cancer)

1/2023CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer.
1/2022miR-130b suppresses the invasion and migration of prostate cancer via inhibiting DLL1 and regulating the PI3K/Akt pathways.
1/2022RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer.
4/2019UNC5D, suppressed by promoter hypermethylation, inhibits cell metastasis by activating death-associated protein kinase 1 in prostate cancer.
1/2019Selective targeting of PARP-2 inhibits androgen receptor signaling and prostate cancer growth through disruption of FOXA1 function.
1/2019Targeting the MIF/CXCR7/AKT Signaling Pathway in Castration-Resistant Prostate Cancer.
1/2018Functional roles and potential clinical application of miRNA-345-5p in prostate cancer.
9/2017The association between germline BRCA2 variants and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancer.
6/2017Androgen receptor-regulated miRNA-193a-3p targets AJUBA to promote prostate cancer cell migration.
1/2017Androgen receptor-mediated downregulation of microRNA-221 and -222 in castration-resistant prostate cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Li Jia Research Topics

Disease

137Neoplasms (Cancer)
03/2024 - 02/2004
34Neoplasm Metastasis (Metastasis)
06/2024 - 06/2006
28Breast Neoplasms (Breast Cancer)
03/2024 - 11/2007
28Prostatic Neoplasms (Prostate Cancer)
01/2023 - 03/2003
18Hepatocellular Carcinoma (Hepatoma)
01/2023 - 06/2006
13Carcinogenesis
01/2022 - 06/2006
10Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2017
9Inflammation (Inflammations)
02/2024 - 10/2013
9Leukemia
08/2023 - 12/2008
7Lung Neoplasms (Lung Cancer)
02/2023 - 04/2016
6Lymphatic Metastasis
06/2021 - 06/2006
6Ovarian Neoplasms (Ovarian Cancer)
11/2019 - 06/2008
6B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2019 - 03/2008
5Infections
03/2024 - 06/2008
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/2023 - 09/2014
5Stomach Neoplasms (Stomach Cancer)
01/2023 - 10/2010
5Fibrosis (Cirrhosis)
01/2023 - 01/2016
5Melanoma (Melanoma, Malignant)
07/2022 - 01/2017
5Obesity
08/2021 - 05/2017
5Insulin Resistance
08/2021 - 05/2017
5Renal Cell Carcinoma (Grawitz Tumor)
01/2020 - 12/2015
5Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2020 - 01/2012
5Callosities
04/2009 - 06/2007
4Mastitis
02/2024 - 01/2021
4Dermatitis
01/2023 - 01/2016
4Thyroid Neoplasms (Thyroid Cancer)
01/2022 - 04/2015
4Metabolic Diseases (Metabolic Disease)
08/2021 - 05/2019
4Adenocarcinoma
09/2019 - 02/2015
3Esophageal Neoplasms (Esophageal Cancer)
06/2024 - 01/2021
3Alzheimer Disease (Alzheimer's Disease)
11/2023 - 01/2017
3Parkinson Disease (Parkinson's Disease)
11/2023 - 01/2018
3Body Weight (Weight, Body)
11/2022 - 05/2017
3Type 2 Diabetes Mellitus (MODY)
08/2021 - 05/2019
3Mitochondrial Diseases (Mitochondrial Disease)
05/2021 - 01/2013
3Non-alcoholic Fatty Liver Disease
05/2021 - 11/2016
3Wounds and Injuries (Trauma)
05/2021 - 01/2013
3Chronic Kidney Failure (Chronic Renal Failure)
05/2021 - 12/2017
3Pain (Aches)
05/2021 - 01/2016
3Lymphoma (Lymphomas)
01/2019 - 01/2007
3Carcinoma (Carcinomatosis)
01/2019 - 02/2014
3Myocarditis (Carditis)
01/2019 - 01/2018

Drug/Important Bio-Agent (IBA)

32MicroRNAs (MicroRNA)IBA
01/2024 - 08/2015
29Proteins (Proteins, Gene)FDA Link
06/2024 - 09/2004
19Biomarkers (Surrogate Marker)IBA
03/2024 - 01/2007
18Androgen Receptors (Androgen Receptor)IBA
01/2019 - 04/2004
13Polysaccharides (Glycans)IBA
02/2024 - 02/2013
12Long Noncoding RNAIBA
04/2022 - 01/2018
10AntigensIBA
03/2024 - 09/2014
10AndrogensIBA
01/2019 - 09/2004
9Messenger RNA (mRNA)IBA
01/2024 - 02/2008
8CytokinesIBA
01/2020 - 02/2013
8Doxorubicin (Adriamycin)FDA LinkGeneric
08/2019 - 11/2012
8LigandsIBA
01/2019 - 03/2003
8TeaIBA
12/2013 - 11/2007
7IronIBA
11/2023 - 05/2019
7CateninsIBA
08/2023 - 01/2015
7Small Interfering RNA (siRNA)IBA
12/2022 - 06/2008
6AntioxidantsIBA
02/2024 - 06/2006
6Glycoproteins (Glycoprotein)IBA
01/2022 - 04/2006
6RNA (Ribonucleic Acid)IBA
01/2022 - 09/2004
6T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2022 - 11/2018
6Vitamin EFDA LinkGeneric
11/2010 - 01/2008
5Interleukin-6 (Interleukin 6)IBA
02/2024 - 01/2016
5Acetic Acid (Vinegar)FDA LinkGeneric
02/2024 - 01/2008
5Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2023 - 01/2019
5epigallocatechin gallate (epigallocatechin-3-gallate)IBA
01/2023 - 01/2016
5Transcription Factors (Transcription Factor)IBA
12/2022 - 01/2008
5Antineoplastic Agents (Antineoplastics)IBA
08/2021 - 06/2008
5Hormones (Hormone)IBA
01/2018 - 04/2004
5FucosyltransferasesIBA
01/2017 - 09/2014
5Bortezomib (Velcade)FDA Link
12/2013 - 01/2007
4Glucose (Dextrose)FDA LinkGeneric
06/2024 - 05/2019
4PeriostinIBA
03/2024 - 06/2018
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2023 - 05/2004
4LipidsIBA
08/2021 - 01/2018
4HMGB1 Protein (HMG1)IBA
08/2019 - 03/2014
4SialyltransferasesIBA
05/2019 - 02/2014
4DNA (Deoxyribonucleic Acid)IBA
04/2016 - 01/2008
4VitaminsIBA
12/2013 - 06/2007
4alpha-TocopherolFDA Link
10/2010 - 01/2008
4Caveolin 1IBA
03/2009 - 01/2006
3EnzymesIBA
02/2023 - 10/2010
3Therapeutic UsesIBA
01/2023 - 01/2019
3SolutionsIBA
01/2023 - 01/2016
3Photosensitizing Agents (Photosensitizers)IBA
12/2022 - 12/2013
3AcidsIBA
12/2022 - 01/2008
31-phenyl-3,3-dimethyltriazene (PDT)IBA
12/2022 - 09/2012
3Circular RNAIBA
10/2022 - 01/2020
3Fluorouracil (Carac)FDA LinkGeneric
01/2022 - 12/2017
3Liposomes (Liposome)IBA
08/2021 - 11/2007
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2021 - 01/2007
3Competitive Endogenous RNAIBA
01/2020 - 01/2018
3Apoptosis Regulatory ProteinsIBA
01/2019 - 06/2008

Therapy/Procedure

43Therapeutics
03/2024 - 10/2008
14Drug Therapy (Chemotherapy)
03/2024 - 04/2013
13Immunotherapy
12/2023 - 12/2016
12Castration
01/2019 - 05/2012
9Radiotherapy
01/2023 - 08/2009
3Photochemotherapy (Photodynamic Therapy)
12/2022 - 09/2012
3Cell- and Tissue-Based Therapy (Cell Therapy)
11/2019 - 11/2018